| SC 13D/A | 2024-02-08 | Valence Investments SPV VI, LLC | CalciMedica, Inc. | 356,989 | 3.5% | EDGAR |
| SC 13G/A | 2024-02-08 | Soleus Capital Master Fund, L.P. | CalciMedica, Inc. | 783,904 | 7.0% | EDGAR |
| SC 13G/A | 2024-02-07 | BML Investment Partners, L.P. | CalciMedica, Inc. | 145,424 | 1.4% | EDGAR |
| SC 13D/A | 2024-02-05 | ORBIMED ADVISORS LLC | CalciMedica, Inc. | 297,380 | 2.9% | EDGAR |
| SC 13G | 2024-02-01 | Flynn James E | CalciMedica, Inc. | 2,613,012 | 10.0% | EDGAR |
| SC 13G | 2024-02-01 | Aisling Capital V, LP | CalciMedica, Inc. | 1,042,228 | 5.1% | EDGAR |
| SC 13G | 2024-01-31 | Stonepine Capital Management, LLC | CalciMedica, Inc. | 1,045,204 | 9.7% | EDGAR |
| SC 13G | 2024-01-26 | Soleus Capital Master Fund, L.P. | CalciMedica, Inc. | 783,904 | 7.4% | EDGAR |
| SC 13D/A | 2023-11-22 | Valence Investments SPV VI, LLC | CalciMedica, Inc. | 356,989 | 6.3% | EDGAR |
| SC 13D/A | 2023-05-23 | Flynn James E | CalciMedica, Inc. | 122,419 | 2.2% | EDGAR |
| SC 13D | 2023-03-30 | Valence Investments SPV VI, LLC | CalciMedica, Inc. | 356,989 | 6.5% | EDGAR |
| SC 13G | 2023-03-30 | REVELATION HEALTHCARE FUND I, L.P. | CalciMedica, Inc. | 542,029 | 9.8% | EDGAR |
| SC 13D/A | 2023-03-28 | Flynn James E | CalciMedica, Inc. | 122,419 | 2.2% | EDGAR |
| SC 13D/A | 2023-03-27 | Flynn James E | CalciMedica, Inc. | 122,419 | 2.2% | EDGAR |
| SC 13D/A | 2023-03-24 | ORBIMED ADVISORS LLC | CalciMedica, Inc. | 297,380 | 5.4% | EDGAR |
| SC 13G/A | 2023-02-13 | AFFAMED PROJECT Ltd | GRAYBUG VISION, INC. | - | 0.0% | EDGAR |
| SC 13G/A | 2023-02-08 | BML Investment Partners, L.P. | GRAYBUG VISION, INC. | 1,235,943 | 5.7% | EDGAR |
| SC 13G | 2022-12-01 | BML Investment Partners, L.P. | GRAYBUG VISION, INC. | 1,235,943 | 5.7% | EDGAR |
| SC 13D/A | 2022-11-23 | Flynn James E | GRAYBUG VISION, INC. | 1,713,873 | 8.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Hatteras Venture Partners IV SBIC, LP | GRAYBUG VISION, INC. | 0 | 0.0% | EDGAR |